Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
6
HHS Quote, Financials, Valuation and Earnings
Last price:
$3.43
Seasonality move
:
-2.95%
Day range:
$3.37 - $3.39
52-week range:
$3.24 - $8.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.14x
P/B ratio:
1.17x
Volume:
1.6K
Avg. volume:
22.5K
1-year change:
-59.74%
Market cap:
$25M
Revenue:
$185.2M
EPS (TTM):
-$4.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 416.22% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has underperformed the S&P 500 by -10.14% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Harte-Hanks reported revenues of $41.6M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of -$0.05.
Enterprise value:
16M
EV / Invested capital:
--
Price / LTM sales:
0.14x
EV / EBIT:
2.72x
EV / Revenue:
0.09x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-11.12x
Price / Operating cash flow:
167.22x
Enterprise value / EBITDA:
1.55x
Gross Profit (TTM):
$124.4M
Return On Assets:
-28.59%
Net Income Margin (TTM):
-16.83%
Return On Equity:
-145.7%
Return On Invested Capital:
-145.7%
Operating Margin:
1.92%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $204.3M | $189.8M | $181.4M | $45.4M | $41.6M | |
| Gross Profit | $140.7M | $131M | $124.4M | $31.7M | $27.5M | |
| Operating Income | $12.3M | $9.2M | $7.2M | $1.2M | $798K | |
| EBITDA | $15.4M | $12M | $10.3M | $815K | $509K | |
| Diluted EPS | $4.26 | -$0.13 | -$4.20 | -$0.02 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $83.9M | $79.9M | $62.2M | $57.8M | $53.7M | |
| Total Assets | $116.9M | $111.1M | $114.9M | $113.4M | $100.6M | |
| Current Liabilities | $53.1M | $44.6M | $38.3M | $40.2M | $36.1M | |
| Total Liabilities | $161.6M | $122M | $93.9M | $93.5M | $79.2M | |
| Total Equity | -$44.7M | -$10.8M | $21M | $20M | $21.4M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $31.3M | $3.1M | $1.9M | -$5.7M | -$818K | |
| Cash From Investing | -$10.7M | -$2.3M | -$3.3M | -$525K | -$103K | |
| Cash From Financing | -$15.8M | -$3.1M | -$338K | -$149K | -$68K | |
| Free Cash Flow | $26.3M | $309K | -$1.4M | -$6.2M | -$923K | |
HHS
Sector
Market Cap
$25M
$85.7M
Price % of 52-Week High
39.79%
71.43%
Dividend Yield
0%
0%
Shareholder Yield
0.67%
3.73%
1-Year Price Total Return
-59.74%
-9.01%
Beta (5-Year)
-0.265
0.572
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.65
200-day SMA
Sell
Level
$5.30
Bollinger Bands (100)
Sell
Level
4.06 - 4.96
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$3.78
Relative Strength Index (RSI14)
Sell
Level
32.87
ADX Line
Buy
Level
19.35
Williams %R
Buy
Level
-98.1982
50-day SMA
Sell
Level
$4.21
MACD (12, 26)
Sell
Level
-0.19
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
715K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.7752)
Sell
CA Score
(Annual)
Level (-0.955)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.0254)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $3.43 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $3.39 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
